The focus of the National Biologics Facility (NBF) is production of high-quality recombinant proteins in pre-clinical or clinical quantities.

The NBF specialises in use of mammalian cell expression technology for proteins with potential therapeutic or commercial uses. The facility was established in 2007 to assist Australian biotechnology companies and academic researchers to bridge the gap between laboratory experiments and the well-characterised cell line and bioprocesses required to produce material at the pilot scale. The NBF has a proven track record in mammalian cell line development and recombinant protein expression and purification at the Queensland node, and various expression systems at the CSIRO's Victoria node.

The Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland (UQ) houses the Queensland facility in a specially designed $13 million facility of labs, clean rooms and state-of-the-art equipment. The NBF has a staff of scientists and bioprocess engineers with world-class expertise in molecular biology, antibody engineering, mammalian cell culture, biopharmaceutical development and associated current Good Manufacturing Practices (cGMP). 

The NBF specialises in:
  • Cell line development
  • Antibody engineering
  • Biologics production
  •  Protein analytics.
For more information, email Dr Jeff Hou or Dr Martina Jones at the Queensland node or Prof George Lovrecz at the Victorian node.
National Biologics Facility - Queensland Node section

National Biologics Facility website

On this site

Go to top